The Regents Of The University Of California

The Regents Of The University Of California operates as a federal grant sub-recipient, delivering research and development services across biomedical, immunological, and quantum-computing domains to federal health and science agencies. The vendor is a state entity — a child of the State of California Controllers Office — and competes exclusively in full-and-open federal grant programs rather than through set-asides or procurement contracts.

Regents' recent federal footprint is research-focused and fragmented across multiple NIH institutes, the Department of Veterans Affairs, and the National Endowment for the Arts. The top five customer agencies account for 65% of awards by count, with the National Endowment for the Arts placing the most task-order volume (7 awards), but dollar concentration concentrated in health research: the Department of Veterans Affairs Veterans Integrated Service Network 22 carries $148 thousand in combined potential value, and the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases executed 2 awards. Regents acts as prime recipient on 85% of recent awards and as a sub-recipient on 15%, predominantly as a sub-grantee under NIH-funded program project grants and University of Pittsburgh quantum-computing research initiatives. Representative recent work includes nanoparticle formulation and antibody conjugation for kidney-disease and immunological research under a Beth Israel Deaconess Medical Center NIH program project grant (sub-award July 30, 2026), lymph-node tissue engineering and immune-therapeutic delivery mechanisms under a second Beth Israel Deaconess NIH sub-award (July 16, 2026), and topological spin qubit development based on graphene nanoribbons as a sub-recipient under a University of Pittsburgh NSF-supported quantum-research award (April 2, 2026).

Activity volume is episodic and sparse. The source records twenty total awards spanning 2004 to July 2026, concentrated in 2007–2008 (eleven awards across two years), with only one award in 2009, one in 2010, and three in 2026. Combined potential value stands at $332 thousand, but $3 million in actual obligations have flowed across the portfolio, indicating substantial work completion relative to reported ceiling. Regents' work clusters in medical laboratory services, professional scientific and technical services, and drug and biologics development, with top NAICS categories reflecting laboratory-based research support and expert-witness consulting roles.